{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T13:45:08Z","timestamp":1649166308855},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[1989,8,1]],"date-time":"1989-08-01T00:00:00Z","timestamp":617932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Agents and Actions"],"published-print":{"date-parts":[[1989,8]]},"DOI":"10.1007\/bf02022980","type":"journal-article","created":{"date-parts":[[2005,8,5]],"date-time":"2005-08-05T21:35:02Z","timestamp":1123277702000},"page":"53-61","source":"Crossref","is-referenced-by-count":5,"title":["Rocastine (AHR-11325), a rapid acting, nonsedating antihistamine"],"prefix":"10.1007","volume":"28","author":[{"given":"J. C.","family":"Nolan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. G.","family":"Proakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. N.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. F.","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. H.","family":"Foxwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Yanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02022980_CR1","first-page":"27","volume":"30","author":"A. Nicholson","year":"1986","unstructured":"A. Nicholson and B. Stone,Antihistamines: impaired performance and the tendency to sleep. Eur. J. Pharmacol.30, 27\u201332 (1986).","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"BF02022980_CR2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/sleep\/7.2.137","volume":"7","author":"T. Roehrs","year":"1984","unstructured":"T. Roehrs, E. Tietz, F. Zorick and T. Roth,Daytime sleepiness and antihistamines. Sleep7(2), 137\u2013141 (1984).","journal-title":"Sleep"},{"key":"BF02022980_CR3","first-page":"247","volume":"8","author":"A. Nicholson","year":"1987","unstructured":"A. Nicholson,New antihistamines free of sedative side effects. Tips8, 247\u2013249 (1987).","journal-title":"Tips"},{"issue":"5\/6","key":"BF02022980_CR4","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/BF01978891","volume":"14","author":"A. Barnett","year":"1984","unstructured":"A. Barnett, L. Iorio, W. Kreutner, S. Tozzi, H. Ahn and A. Gulbenkian,Evaluation of the CNS properties of SCH 29851, a potential nonsedating antihistamine. Agents and Actions14(5\/6), 590\u2013597 (1984).","journal-title":"Agents and Actions"},{"key":"BF02022980_CR5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(86)90219-0","volume":"127","author":"A. Ahn","year":"1986","unstructured":"A. Ahn and A. Barnett,Selective displacement of [3H]mepyramine from peripheral vs. central nervous system receptors by loratadine. Eur. J. Pharmacol.127, 153\u2013155 (1986).","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"BF02022980_CR6","first-page":"1167","volume":"32","author":"N. Weich","year":"1982","unstructured":"N. Weich and J. Martin,Absence of an effect of terfenadine on guinea pig brain histamine H 1-receptors in vivo determined by receptor binding techniques. Arzneim.-Forsch.\/Drug Res.32(11) 1167\u20131170 (1982).","journal-title":"Arzneim.-Forsch.\/Drug Res."},{"key":"BF02022980_CR7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0014-2999(87)90206-8","volume":"133","author":"C. Calcutt","year":"1987","unstructured":"C. Calcutt, C. Ganellin, B. Jackson, B. Leigh, D. Owen and I. Smith,Evidence for low brain penetration by the H 1-receptor antagonist temelastine (SK & F 93944). Eur. J. Pharmacol.133, 67\u201374 (1987).","journal-title":"Eur. J. Pharmacol."},{"key":"BF02022980_CR8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1476-5381.1986.tb10199.x","volume":"87","author":"E. Brown","year":"1986","unstructured":"E. Brown, R. Griffiths, C. Harvey and D. Owen,Pharmacological studies with SK&F 93944 (temelastine), a novel histamine H 1-receptor antagonist with negligible ability to penetrate the central nervous system. Br. J. Pharmac.87, 569\u2013578 (1986).","journal-title":"Br. J. Pharmac."},{"key":"BF02022980_CR9","first-page":"39","volume":"251","author":"J. Wauwe Van","year":"1981","unstructured":"J. Van Wauwe, F. Awouters, C. Neimegeers, F. Janssens, J. Vannueten and P. Janssen,In vivo pharmacology of astemizole, a new type of H 1-antihistaminic compound. Arch. Int. Pharmacodyn.251, 39\u201351 (1981).","journal-title":"Arch. Int. Pharmacodyn."},{"key":"BF02022980_CR10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0028-3908(72)90004-4","volume":"11","author":"C. Faingold","year":"1972","unstructured":"C. Faingold and C. Berry,Effects of antihistamine agents upon the electrographic activity of the cat brain: a power spectral density study. Neuropharmacology11, 491\u2013498 (1972).","journal-title":"Neuropharmacology"},{"key":"BF02022980_CR11","first-page":"180","volume":"25","author":"R. Ruckart","year":"1983","unstructured":"R. Ruckart and D. Johnson,Effects of antihistaminic agents on sleep patterns in cats: A new method for detecting sedative potential. Pharmacologist25 (Abstract) 180 (1983).","journal-title":"Pharmacologist"},{"key":"BF02022980_CR12","first-page":"97","volume":"26","author":"G. Bruce","year":"1984","unstructured":"G. Bruce, R. Tabor, M. Haimes-Bartolf and W. Kinner,Effect of AHR-11325 on lung and brain histamine receptors. Pharmacologist26 (Abstract), 97 (1984).","journal-title":"Pharmacologist"},{"key":"BF02022980_CR13","first-page":"222","volume":"26","author":"R. Ruckart","year":"1984","unstructured":"R. Ruckart, B. Turley, S. Erdle and D. Johnson,CNS effects of AHR-11325, a new nonsedative antihistamine. Pharmacologist26 (Abstract), 222 (1984).","journal-title":"Pharmacologist"},{"key":"BF02022980_CR14","first-page":"221","volume":"26","author":"C. Leonard","year":"1984","unstructured":"C. Leonard, C. Jackson, D. Stephens, A. Proakis, R. Alphin,AHR-11325, a new antihistamine agent. Pharmacologist26 (Abstract), 221 (1984).","journal-title":"Pharmacologist"},{"key":"BF02022980_CR15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1476-5381.1981.tb10470.x","volume":"74","author":"P. Anderson","year":"1981","unstructured":"P. Anderson and H. Bergstrand,Antigen-induced bronchial anaphylaxis in actively sensitized guinea pigs: effect of longterm treatment with sodium cromoglycate and aminophylline. Br. J. Pharmacol.74, 601\u2013609 (1981).","journal-title":"Br. J. Pharmacol."},{"key":"BF02022980_CR16","first-page":"51","volume":"21","author":"R. Quinton","year":"1963","unstructured":"R. Quinton,The increase in toxicity of yohimbine induced by imipramine and other drugs in mice. Br. J. Pharmacol.21, 51\u201366 (1963).","journal-title":"Br. J. Pharmacol."},{"key":"BF02022980_CR17","volume-title":"Antidepressants: neurochemical, behavioral and clinical perspectives","author":"J. Malick","year":"1981","unstructured":"J. Malick,Yohimbine potentiation as a predictor of antidepressant action. In:Antidepressants: neurochemical, behavioral and clinical perspectives. Raven Press, New York (1981)."},{"key":"BF02022980_CR18","first-page":"229","volume":"143","author":"J. Rossum Van","year":"1963","unstructured":"J. Van Rossum,Cummulative dose-response curves. II. Techniques for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch. int. Pharmacodyn.143, 229\u2013330 (1963).","journal-title":"Arch. int. Pharmacodyn."},{"key":"BF02022980_CR19","first-page":"48","volume":"14","author":"O. Arunlakshana","year":"1959","unstructured":"O. Arunlakshana and H. SchildSome quantitative uses of drug antagonists. Br. J. Pharmacol.14, 48\u201358 (1959).","journal-title":"Br. J. Pharmacol."},{"key":"BF02022980_CR20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0014-2999(78)90177-2","volume":"48","author":"R. Chang","year":"1978","unstructured":"R. Chang, V. Tran and S. Snyder,Histamine H 1-receptors in brain labeled with 3-H-mepyramine. Eur. J. Pharmacol.48, 463\u2013464 (1978).","journal-title":"Eur. J. Pharmacol."},{"issue":"17","key":"BF02022980_CR21","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1016\/S0021-9258(17)34565-9","volume":"253","author":"W. Clarke","year":"1978","unstructured":"W. Clarke, L. Jones and R. Lefkowitz,Hepatic alphadrenergic receptors. J. Biol. Chem.253(17), 5975\u20135979 (1978).","journal-title":"J. Biol. Chem."},{"key":"BF02022980_CR22","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1073\/pnas.71.5.1725","volume":"71","author":"H. Yamamura","year":"1974","unstructured":"H. Yamamura and S. Snyder,Muscarinic cholinergic binding in rat brain. PNAS, USA,71, 1725\u20131729 (1974).","journal-title":"PNAS, USA"},{"key":"BF02022980_CR23","first-page":"301","volume":"21","author":"J. Leysen","year":"1982","unstructured":"J. Leysen, J. Niemegeers, J. Van Hueten and P. Laduron, [3H]Ketanserin (R 41 468), a selective 3 H-ligand for serotonin 2 receptor binding sites. Mol. Pharmacol.21, 301\u2013314 (1982).","journal-title":"Mol. Pharmacol."},{"key":"BF02022980_CR24","first-page":"31","volume-title":"Receptor binding in drug research","author":"J. Lundeen","year":"1986","unstructured":"J. Lundeen,Computer analysis of binding data. InReceptor binding in drug research. Ed. by R.A. O'Brien, Dekker NY, 31\u201349 (1986)."},{"key":"BF02022980_CR25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2362.1976.tb00500.x","volume":"6","author":"C. Perrier","year":"1976","unstructured":"C. Perrier, M. Griessen,Action of H 1 and H2 inhibitors on the response of histamine sensitive adenylate cyclase from guineapig mucosa. Eur. J. Clin. Invest.6, 113\u2013120 (1976).","journal-title":"Eur. J. Clin. Invest."},{"key":"BF02022980_CR26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1073\/pnas.67.1.305","volume":"67","author":"A. Gilman","year":"1970","unstructured":"A. Gilman,A protein binding assay for adenosine 3\u2032, 5\u2032-monophosphate. PNAS, USA,67, 305\u2013312 (1970).","journal-title":"PNAS, USA"},{"key":"BF02022980_CR27","first-page":"99","volume":"96","author":"J. Litchfield","year":"1949","unstructured":"J. Litchfield and F. Wilcoxon,A simplified method for evaluating dose-effect experiments. J. Pharmac. Exp. Ther.96, 99\u2013113 (1949).","journal-title":"J. Pharmac. Exp. Ther."},{"key":"BF02022980_CR28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1476-5381.1967.tb02135.x","volume":"30","author":"H. Collier","year":"1967","unstructured":"H. Collier and G. James,Humoral factors affecting pulmonary inflation during acute anaphylaxis in the guinea pig in vivo. Br. J. Pharmacol. Chemother.30, 283\u2013301 (1967).","journal-title":"Br. J. Pharmacol. Chemother."},{"issue":"4","key":"BF02022980_CR29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/BF01965229","volume":"4","author":"S. Tozzi","year":"1974","unstructured":"S. Tozzi, F. Roth and I. Tabachnick,The pharmacology of azatadine, a potential antiallergy drug. Agents Actions4(4), 264\u2013270 (1974).","journal-title":"Agents Actions"},{"key":"BF02022980_CR30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2165\/00003495-198428010-00003","volume":"28","author":"D. Richards","year":"1984","unstructured":"D. Richards, R. Brogden, R. Heel, t. Speight and G. Avery,Astemizole a review of its pharmacodynamic properties and therapeutic efficacy. Drugs28, 38\u201361 (1984a).","journal-title":"Drugs"},{"key":"BF02022980_CR31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1398-9995.1987.tb02188.x","volume":"42","author":"W. Kreutner","year":"1987","unstructured":"W. Kreutner, R. Chapman, A. Gulbenkian, M. Siegel,Antiallergic activity of loratadine, a nonsedating antihistamine. Allergy42, 57\u201363 (1987).","journal-title":"Allergy"},{"key":"BF02022980_CR32","first-page":"217","volume":"232","author":"J. Neuten Van","year":"1978","unstructured":"J. Van Neuten, R. Xhonneux and P. Janssen,Preliminary data on antiseratonin effects of oxatomide, a novel antiallergic compound Arch. int. Pharmacodyn.232, 217\u2013220 (1978).","journal-title":"Arch. int. Pharmacodyn."},{"key":"BF02022980_CR33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ddr.430020208","volume":"2","author":"H. Cheng","year":"1982","unstructured":"H. Cheng and J. Woodward,Antihistaminc effect of terfenadine: a new piperidine-type antihistamine. Drug Dev. Res.2, 181\u2013196 (1982).","journal-title":"Drug Dev. Res."},{"key":"BF02022980_CR34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2165\/00003495-198427030-00003","volume":"27","author":"D. Richards","year":"1984","unstructured":"D. Richards, R. Brogden, R. Heel, T. Speight and G. Avery,Oxatomide a review of its pharmacodynamic properties and therapeutic efficacy. Drugs27, 210\u2013231 (1984b).","journal-title":"Drugs"},{"key":"BF02022980_CR35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1021\/bk-1980-0118.ch010","volume":"118","author":"F. Awouters","year":"1979","unstructured":"F. Awouters, C. Niemegeers, P. Janssen, M. Janssen, J. Van Denberk, L. Kennis, M. Van Der Aa and A. Van Heertum,Oxatomide: the prototype of a chemical series of compounds inhibiting both the release and the effects of allergic mediators. ACS Symposium Series118, 179\u2013208 (1979).","journal-title":"ACS Symposium Series"},{"key":"BF02022980_CR36","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/106002808501901103","volume":"19","author":"C. Carter","year":"1985","unstructured":"C. Carter, N. Wojciechowski, J. Hayes, V. Skoutakis and L. Rickman,Terfenadine, a nonsedating antihistamine. Drug. Intell. Clin. Phar.19, 812\u2013817 (1985).","journal-title":"Drug. Intell. Clin. Phar."}],"container-title":["Agents and Actions"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02022980.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02022980\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02022980","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T23:14:29Z","timestamp":1626304469000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02022980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,8]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1989,8]]}},"alternative-id":["BF02022980"],"URL":"https:\/\/doi.org\/10.1007\/bf02022980","relation":{},"ISSN":["0065-4299","1420-908X"],"issn-type":[{"value":"0065-4299","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,8]]}}}